Primary signet ring cell carcinoma of the pancreatic head: A case report
Abstract Pancreatic SRCC is a rare, aggressive tumor. Given limited evidence and the risk of side effects, physicians may elect to withhold chemotherapy in select patients, with the exception of neoadjuvant chemotherapy use to facilitate resectability.
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2019-11-01
|
| Series: | Clinical Case Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/ccr3.2475 |
| _version_ | 1798043284808925184 |
|---|---|
| author | Dheeraj Alexander Lewis Rashid Michael Hollis Srinivas Kavuturu |
| author_facet | Dheeraj Alexander Lewis Rashid Michael Hollis Srinivas Kavuturu |
| author_sort | Dheeraj Alexander |
| collection | DOAJ |
| description | Abstract Pancreatic SRCC is a rare, aggressive tumor. Given limited evidence and the risk of side effects, physicians may elect to withhold chemotherapy in select patients, with the exception of neoadjuvant chemotherapy use to facilitate resectability. |
| first_indexed | 2024-04-11T22:47:12Z |
| format | Article |
| id | doaj.art-5e185fbd335d463580a4223c00fa4f69 |
| institution | Directory Open Access Journal |
| issn | 2050-0904 |
| language | English |
| last_indexed | 2024-04-11T22:47:12Z |
| publishDate | 2019-11-01 |
| publisher | Wiley |
| record_format | Article |
| series | Clinical Case Reports |
| spelling | doaj.art-5e185fbd335d463580a4223c00fa4f692022-12-22T03:58:43ZengWileyClinical Case Reports2050-09042019-11-017112235223810.1002/ccr3.2475Primary signet ring cell carcinoma of the pancreatic head: A case reportDheeraj Alexander0Lewis Rashid1Michael Hollis2Srinivas Kavuturu3Department of General Surgery Michigan State University Lansing MI USADepartment of General Surgery Michigan State University Lansing MI USADepartment of General Surgery Michigan State University Lansing MI USADepartment of General Surgery Michigan State University Lansing MI USAAbstract Pancreatic SRCC is a rare, aggressive tumor. Given limited evidence and the risk of side effects, physicians may elect to withhold chemotherapy in select patients, with the exception of neoadjuvant chemotherapy use to facilitate resectability.https://doi.org/10.1002/ccr3.2475chemotherapypancreatic cancerpancreaticoduodenectomySignet ring cell carcinoma |
| spellingShingle | Dheeraj Alexander Lewis Rashid Michael Hollis Srinivas Kavuturu Primary signet ring cell carcinoma of the pancreatic head: A case report Clinical Case Reports chemotherapy pancreatic cancer pancreaticoduodenectomy Signet ring cell carcinoma |
| title | Primary signet ring cell carcinoma of the pancreatic head: A case report |
| title_full | Primary signet ring cell carcinoma of the pancreatic head: A case report |
| title_fullStr | Primary signet ring cell carcinoma of the pancreatic head: A case report |
| title_full_unstemmed | Primary signet ring cell carcinoma of the pancreatic head: A case report |
| title_short | Primary signet ring cell carcinoma of the pancreatic head: A case report |
| title_sort | primary signet ring cell carcinoma of the pancreatic head a case report |
| topic | chemotherapy pancreatic cancer pancreaticoduodenectomy Signet ring cell carcinoma |
| url | https://doi.org/10.1002/ccr3.2475 |
| work_keys_str_mv | AT dheerajalexander primarysignetringcellcarcinomaofthepancreaticheadacasereport AT lewisrashid primarysignetringcellcarcinomaofthepancreaticheadacasereport AT michaelhollis primarysignetringcellcarcinomaofthepancreaticheadacasereport AT srinivaskavuturu primarysignetringcellcarcinomaofthepancreaticheadacasereport |